A prospective study of hepatic safety of statins used in very elderly patients
Abstract Background Statins play an important role in the care of patients with cardiovascular disease and have a good safety record in clinical practice. Hepatotoxicity is a barrier that limits the ability of primary care physicians to prescribe statins for patients with elevated liver transaminase...
Main Authors: | Meizi Guo, Junli Zhao, Yingjiu Zhai, Panpan Zang, Qing Lv, Dongya Shang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-12-01
|
Series: | BMC Geriatrics |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12877-019-1361-2 |
Similar Items
-
Statin Hepatotoxicity: Is it a Real Concern?
by: Pranav Sikka, et al.
Published: (2011-01-01) -
Statin intolerance: Now a solved problem
by: P Sikka, et al.
Published: (2011-01-01) -
Pharmacotherapy with statins in highand very high-risk elderly patients
by: V. V. Simerzin, et al.
Published: (2020-11-01) -
Are statins really wonder drugs?
by: Harpreet Singh Grover, et al.
Published: (2014-12-01) -
Statin therapy and hepatotoxicity: Appraisal of the safety profile of atorvastatin in hyperlipidemic patients
by: Saeed Kalantari, et al.
Published: (2014-01-01)